Bizarre Patents
A fork with timer for providing a cue to a user after an elapsed period of time for indicating that another bite of food using the fork may be taken.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7351826 | Aryl acid pyrimidinyl methyl amides, pyridazinyl methyl amides and related compounds The invention provides compounds of Formula (I) that bind to GABAA receptors. In the above formula, variables are defined herein. Such compounds may be used to modulate ligand binding to GABAA receptors in vivo or in vitro, and are particularly... | 04/01/2008 |
| 7265155 | Treating a variety of pathological conditions, including spasticity and convulsions, by effecting a modulation of CNS activity with isovaleramide, isovaleric acid, or a related compound Preparations and extracts of valerian, as well as isovaleramide, isovaleric acid, and certain structurally related compounds, exhibit clinically significant pharmacological properties that implicate a treatment for a variety of pathological conditions, including spa... | 09/04/2007 |
| 6998112 | Sleep inducing toothpaste made with natural herbs and a natural hormone A toothpaste composition for inducing sleep while simultaneously promoting intraoral cleanliness, which includes toothpaste base ingredients and at least one sleep-inducing natural herb or hormone. The sleep-inducing natural herbs and hormone are selected from the g... | 02/14/2006 |
| 6890569 | Restorative tea system and associated method A restorative tea system and method of brewing a tea of one part White Willow bark, one part German Chamomile, one part Parsley, one part Nettles leaf, and one part primula veris. ... | 05/10/2005 |
| 6716415 | Delivery of sedative-hypnotics through an inhalation route The present invention relates to the delivery of sedative-hypnotics through an inhalation route. Specifically, it relates to aerosols containing sedative-hypnotics that are used in inhalation therapy. In a composition aspect of the present invention, the aerosol com... | 04/06/2004 |
| 6703412 | Method of treating sleeplessness with melatonin on an acute basis A method of treating sleeplessness in a human comprising administering to said human suffering from said sleeplessness an effective sleep-inducing amount of not greater than about 5 mg of melatonin or a pharmaceutically acceptable salt thereof, said admin... | 03/09/2004 |
| 6656473 | Tryptophan source from plants and uses thereof Compositions are described comprising at least partially defatted meal from a plant source containing protein-bound tryptophan, preferably squash seeds, and, optionally, a carbohydrate source provided in an amount capable of facilitating transport of in v... | 12/02/2003 |
| 6586478 | Methods and compositions for improving sleep Methods and compositions for improving sleep in individuals with sleep disorders or other conditions which interfere with normal sleep via administration of a NO-mimetic are provided.... | 07/01/2003 |
| 6485746 | Controlled-release sedative-hypnotic compositions and methods related thereto Controlled-release formulations providing a "pulsed" plasma profile of a sedative-hypnotic compound having a particularly short half-life are provided. The formulation contains a sedative-hypnotic compound or precursor thereof that is metabolized to gener... | 11/26/2002 |
| 6462089 | Method for correcting the vigilance disorders associated with myopathies The present invention relates to the use of modafinil and isomers thereof for correcting psychosocial life disturbances due to vigilance disorders observed during the evolution of myopathies.... | 10/08/2002 |
| 6395786 | Sleep inducing agent A sleep-inducing preparation which comprises as an effective ingredient a prostaglandin derivative represented by the formula: ##STR1## wherein X is a halogen atom, Y is a group represented by (CH2)m, a cis-vinylene group or a phenyl... | 05/28/2002 |
| 6391309 | Method of preparing and using isoflavones for the treatment of female symptoms A composition is prepared by extracting phytochemicals from plant matter to form a dietary supplement for treatment of female symptoms. This composition is enriched preferably with two or more fractions of plant matter, namely: isoflavones, lignans, sapon... | 05/21/2002 |
| 6365631 | Method of treating sleep apnoea A compound of formula I ##STR1## or a pharmaceutically acceptable salt thereof in which R1 and R2 are independently H or methyl, including individual enantiomers or racemates thereof, (for example N,N-dimethyl-1-[1-(4-chlorophen... | 04/02/2002 |
| 6358941 | Treatment of arthritis disorders, rheumatoid arthritis and manifestations associated with rheumatoid disorders The present invention relates to the use of pharmaceutically acceptable cholinesterase inhibitors for the preparation of a pharmaceutical composition for the treatment or prophylaxis of arthritic disorders, including osteoarthritis, rheumatoid arthritis a... | 03/19/2002 |
| 6277864 | Use of R- +)--(2,3-dimethoxyphenyl-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol for the treatment of sleep disorders A method of treating a patient for a Sleep Disorder comprising administering an effective amount of R-(+)--(2,3-Dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidi nemethanol or a pharmaceutically acceptable salt thereof to a patient in nee... | 08/21/2001 |
| 6218429 | Tricyclic compounds, their production and use A compound of the formula: ##STR1## wherein R1 is an optionally substituted hydrocarbon, amino or heterocyclic group; R2 is H or an optionally substituted hydrocarbon group; R3 is H or an optionally substituted hydrocarbon... | 04/17/2001 |
| 6211229 | Treatment of transient and short term insomnia The invention is directed to a method for the treatment of a patient suffering from transient or short term insomnia. The claimed method comprises the administration of a compound selected from the group consisting of the pharmaceutically acceptable forms... | 04/03/2001 |
| 6114326 | Use of cabergoline in the treatment of restless legs syndrome The present invention provides for the use of cabergoline and other agents for the treatment of restless legs syndrome (RLS).... | 09/05/2000 |
| 6103766 | Phenylsulfonamide-phenylethylamines useful as dopamine receptors Compounds of Formula I and their pharmaceutically acceptable salts having selective dopamine D3 receptor activity suitable for treating central nervous system disorders. Formula I: ##STR1## R1 is independently H or a C1 -C8... | 08/15/2000 |
| 6090854 | Aryloxyanilides and related compounds There is provided novel aryloxyanilides and related compounds of the formula ##STR1## wherein R1 is --OR, --CO2 R, or halogen with R being C1-4 alkyl; R2 is R, cyclopropyl, C2-4 alkenyl or --CH | 07/18/2000 |
| 5990162 | Method for treatment of fibromyalgia and chronic fatigue syndrome A method is provided to treat a human afflicted with chronic fatigue syndrome or fibromyalgia syndrome by the administration of certain butyrate derivatives.... | 11/23/1999 |
| 5874450 | Intranasal formulations for promoting sleep and method of using the same Intranasal dosage units for promoting sleep in a mammal are disclosed. The dosage units are in the form of an aqueous buffered solution having a pH greater than 7.0, a sleep-promoting amount of Doxylamine, and an effective amount of an anionic surfactant.... | 02/23/1999 |
| 5840331 | Use of γ-hydroxybutyrate for the stimulation of sleep-related secretion growth hormone and prolactin Methods for reestablishing normal nocturnal growth hormone and prolactin secretion in adults with low slow-wave (deep) sleep are provided. In particular, methods are disclosed where γ-hydroxybutyrate is orally administered to subjects just prior to retir... | 11/24/1998 |
| 5786382 | Use of valerian plant and/or root as a scent-attractant for stimulating canines and felines Use of the herb/plant Valerian, in all of its forms, whether whole or in part; powdered, chopped, ground, or "tea"; the root and that portion which grows above ground; in toys; food-products; and medications (though not limited to the preceding applicatio... | 07/28/1998 |
| 5763494 | Pharmaceutical compositions comprising isovaleramide Isovaleramide has been found to exhibit mild anxiolytic activity at low to moderate dosage levels and mildly sedative at somewhat higher dosage levels. In contrast to certain other materials thought to be anxiolytic or mildly sedative, isovaleramide is no... | 06/09/1998 |
| 5661185 | Melatonergic agents New melatonergic agents are phenyl alkanyl or phenyl alkyl substituted carboxamides and ureas of Formula I: ##STR1## wherein: R1 =C1-3 alkyl, allyl, C3-6 cycloalkyl substituted C1-4 alkyl; R2 =hy... | 08/26/1997 |
| 5643897 | Treatment for insomnia A method for the treatment of chronic insomnia is disclosed which involves the administration of low dosages of a compound selected from the pharmaceutically acceptable forms of doxepin, trimipramine, amitriptyline, trazodone and mixtures hereof.... | 07/01/1997 |
| 5641801 | Method of reducing the period before the onset of sleep Methods of inducing sleepiness and sleep in an individual by administering to that individual a single dose of melatonin sufficient to induce sleepiness and sleep in the individual.... | 06/24/1997 |
| 5622704 | Anxiolytic Use of a medicament with a content of active substances from Rhizoma zingiberis and Ginkgo bilobae for the treatment of anxiety states.... | 04/22/1997 |
| 5612380 | Method for sleep induction Sleep may be induced by administration of fatty acid primary amides, including cis-9,10-octadecenoamide. Furthermore, sleep deprivation may be assayed by analyzing cerebrospinal fluid with respect to the presence of fatty acid primary amides, including ci... | 03/18/1997 |
| 5604261 | Arylalkyl (thio)amides A compound which is selected from those of formula (I) : ##STR1## in which A, R1, R2, R3, R4, R5 and R6 are as defined in the description, its optical isomers, and its addition salts t... | 02/18/1997 |
| 5603935 | Composition for the treatment of snoring and methods of use thereof A composition and method for the treatment of snoring comprising an effective amount of discorea villosa and zingiber officinale in a physiologically acceptable carrier, to be administered in the form of nasal drops or spray in the nasal passages of a sub... | 02/18/1997 |
| 5569679 | Pharmacologic management of snoring A method of pharmaceutically managing snoring is provided by the instillation intranasally of a solution containing 1-20% methylsulfonylmethane by weight dissolved in water so as to saturate the nasal mucous membranes. Preferably, the solution has between... | 10/29/1996 |
| 5565201 | Pharmaceutical composition and preparation for the treatment of snoring and the use thereof The present invention relates to a novel composition for the treatment and inhibitation of snoring. The composition according to the present invention comprises a first component and a second component. The first component is selected from Rhizoma dioscor... | 10/15/1996 |
| 5506268 | Use of isovaleramide as a mild anxiolytic and sedative agent Isovaleramide has been found to exhibit mild anxiolytic activity at low to moderate dosage levels and mildly sedative at somewhat higher dosage levels. In contrast to certain other materials thought to be anxiolytic or mildly sedative, isovaleramide is no... | 04/09/1996 |
| 5502047 | Treatment for insomnia A method for the treatment of chronic insomnia is disclosed which involves the administration of low dosages of a compound selected from the pharmaceutically acceptable forms of doxepin, trimipramine, amitriptyline, trazodone and mixtures hereof.... | 03/26/1996 |
| 5449683 | Methods of inducing sleep using melatonin Methods of inducing sleepiness and sleep in an individual by administering to that individual a single dose of melatonin sufficient to induce sleepiness and sleep in the individual.... | 09/12/1995 |
| 5449689 | Naphthylethylureas and naphthylethylthioureas A compound selected from those of formula (I): ##STR1## in which the meanings of R, R1, R2 and X are as defined in the specification, and medicinal products containing the same which are useful in treating or in preventing a dis... | 09/12/1995 |
| 5449690 | Naphthylethylureas and naphthylethylthioureas A compound selected from those of formula (I): ##STR1## in which the meanings of R, R1, R2 and X are as defined in the specification, and medicinal products containing the same which are useful in treating or in preventing a dis... | 09/12/1995 |
| 5430029 | Pharmaceutical compositions active in the therapy of sleep disorders The present invention relates to new pharmaceutical compositions active in the therapy of sleep disorders comprising N-acetyl-5-methoxy-triptamine (melatonin) or one of its derivatives, preferably 2-iodo-N-acetyl-5-methoxy-triptamine (2-iodomelatonin), ... | 07/04/1995 |
